Home
Sanjivani Paranteral Ltd PE Ratio

Sanjivani Paranteral Ltd
NSE: SANJIVPARANT
PE
Key Highlights
- The P/E Ratio of Sanjivani Paranteral Ltd is 41.6 as of 18 Apr 15:30 PM .
- The P/E Ratio of Sanjivani Paranteral Ltd changed from 6.6 on March 2021 to 28.4 on March 2024 . This represents a CAGR of 44.03% over 4 years.
- The Latest Trading Price of Sanjivani Paranteral Ltd is ₹ 251.05 as of 17 Apr 15:30 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.9. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 159.2. The PE Ratio of Textiles industry is 37.1 in 2024.
Historical P/E Ratio of Sanjivani Paranteral Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Sanjivani Paranteral Ltd
Company Fundamentals for Sanjivani Paranteral Ltd

Sanjivani Paranteral Ltd
NSE: SANJIVPARANT
Share Price
Market Price of Sanjivani Paranteral Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
17 Apr 2025 | 251.05 |
16 Apr 2025 | 250.3 |
15 Apr 2025 | 250.05 |
11 Apr 2025 | 234.05 |
09 Apr 2025 | 223.1 |
08 Apr 2025 | 236.95 |
07 Apr 2025 | 231.3 |
04 Apr 2025 | 246.55 |
03 Apr 2025 | 255.85 |
02 Apr 2025 | 244.5 |
SWOT Analysis Of Sanjivani Paranteral Ltd
BlinkX Score for Sanjivani Paranteral Ltd
Asset Value vs Market Value of Sanjivani Paranteral Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Sanjivani Paranteral Ltd | 298.29 | 41.63 |
Sun Pharmaceutical Industries Ltd | 420136 | 35.6 |
Divis Laboratories Ltd | 149680 | 72.4 |
Cipla Ltd | 122390 | 24.5 |
Torrent Pharmaceuticals Ltd | 110154 | 59.2 |
Mankind Pharma Ltd | 106555 | 52.2 |
Company | |
---|---|
Sanjivani Paranteral Ltd | 298.29 |
Sun Pharmaceutical Industries Ltd | 420136 |
Divis Laboratories Ltd | 149680 |
Cipla Ltd | 122390 |
Torrent Pharmaceuticals Ltd | 110154 |
Mankind Pharma Ltd | 106555 |
PE Ratio of Sanjivani Paranteral Ltd Explained
₹298.29
Market cap
₹7
Earnings
41.6X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Sanjivani Paranteral Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Sanjivani Paranteral Ltd
Historical Revenue, EBITDA and Net Profit of Sanjivani Paranteral Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Sanjivani Paranteral Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Sanjivani Paranteral Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Sanjivani Paranteral Ltd
About Sanjivani Paranteral Ltd
- Sanjivani Paranteral Ltd is a WHO-GMP certified core pharmaceutical company and a pioneer in the manufacturing of injectables and oral solids with an extensive experience spanning two-and-a-half-decades.
- The Company primarily focus on life-saving drugs and has exports to over 25 countries, while catering to the needs of a vast geographic area through two WHO-GMP certified manufacturing facilities in Mumbai and Dehradun. Incorporated as a public limited company in Oct.'94, Sanjivani Parenteral was jointly promoted by Anami H Khemka and a team of professionals in various fields of pharmaceutical industry.
- The Company has been involved in the manufacturing of pharmaceutical medicines.
- The Company's products includes oral solids, small volume parenteral and sterile powder formulations. The company is setting up a plant at Taloja, Maharashtra, to manufacture high grade anti-biotics and life saving injectibles used in various infections, pre- and post-operative.
Sanjivani Paranteral Ltd News Hub
Sanjivani Paranteral AGM scheduled
Sanjivani Paranteral announced that the 30th Annual General Meeting (AGM) of the company will be hel
Read more
12 Aug 24
Sanjivani Paranteral standalone net profit rises 10.32% in the June 2024 quarter
Net profit of Sanjivani Paranteral rose 10.32% to Rs 1.71 crore in the quarter ended June 2024 as ag
Read more
06 Aug 24
Sanjivani Paranteral announces board meeting date
Sanjivani Paranteral will hold a meeting of the Board of Directors of the Company on 9 September 202
Read more
05 Sept 24
Sanjivani Paranteral announces board meeting date
Sanjivani Paranteral will hold a meeting of the Board of Directors of the Company on 28 October 2024
Read more
22 Oct 24